ENDRA LIFE SCIENCES INC. Operating Income
ENDRA LIFE SCIENCES INC. (NDRA) reported Operating Income of -$1.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. operating income (loss) for the quarter ending 2026-06-30 was -$1.48M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for the quarter ending 2026-03-31 was -$2.17M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for the quarter ending 2025-12-31 was -$1.62M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for the quarter ending 2025-09-30 was -$1.37M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for fiscal 2025 was -$5.76M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for fiscal 2024 was -$10.82M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for fiscal 2023 was -$10.52M.
- ENDRA LIFE SCIENCES INC. operating income (loss) for fiscal 2022 was -$13.16M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.48M 10-Q · filed 2026-08-14 | -$3.66M 10-Q · filed 2026-08-14 | -$5.28M derived: sum of 3 quarters · filed 2026-08-14 | -$6.65M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$2.17M 10-Q · filed 2026-05-15 | -$3.80M derived: sum of 2 quarters · filed 2026-05-15 | -$5.17M derived: sum of 3 quarters · filed 2026-05-15 | -$6.47M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.99M derived: sum of 2 quarters · filed 2026-03-31 | -$4.29M derived: sum of 3 quarters · filed 2026-08-14 | -$5.76M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$1.37M 10-Q · filed 2025-11-14 | -$2.67M derived: sum of 2 quarters · filed 2026-08-14 | -$4.14M 10-Q · filed 2025-11-14 | -$8.44M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$1.30M 10-Q · filed 2026-08-14 | -$2.77M 10-Q · filed 2026-08-14 | -$7.07M derived: sum of 3 quarters · filed 2026-08-14 | -$8.58M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$1.47M 10-Q · filed 2026-05-15 | -$5.77M derived: sum of 2 quarters · filed 2026-05-15 | -$7.28M derived: sum of 3 quarters · filed 2026-05-15 | -$9.51M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$5.81M derived: sum of 2 quarters · filed 2026-03-31 | -$8.04M derived: sum of 3 quarters · filed 2026-03-31 | -$10.82M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$1.51M 10-Q · filed 2025-11-14 | -$3.74M derived: sum of 2 quarters · filed 2025-11-14 | -$6.52M 10-Q · filed 2025-11-14 | -$7.98M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$2.23M 10-Q · filed 2025-08-14 | -$5.01M 10-Q · filed 2025-08-14 | -$6.47M derived: sum of 3 quarters · filed 2025-08-14 | -$9.60M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$2.78M 10-Q · filed 2025-05-15 | -$4.24M derived: sum of 2 quarters · filed 2025-05-15 | -$7.37M derived: sum of 3 quarters · filed 2025-05-15 | -$10.36M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$1.46M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | -$4.59M derived: sum of 2 quarters · filed 2025-04-07 | -$7.58M derived: sum of 3 quarters · filed 2025-04-07 | -$10.52M 10-K/A · filed 2025-04-07 | ||
| 2023-09-30 | -$3.13M 10-Q/A · filed 2024-11-21 | -$6.12M derived: sum of 2 quarters · filed 2024-11-21 | -$9.06M 10-Q/A · filed 2024-11-21 | -$12.38M derived: sum of 4 quarters · filed 2024-11-21 | ||
| 2023-06-30 | -$2.99M 10-Q · filed 2024-08-14 | -$5.93M 10-Q · filed 2024-08-14 | -$9.25M derived: sum of 3 quarters · filed 2024-08-14 | -$12.66M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$2.94M 10-Q · filed 2024-05-14 | -$6.25M derived: sum of 2 quarters · filed 2024-05-14 | -$9.67M derived: sum of 3 quarters · filed 2024-05-14 | -$13.24M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$6.73M derived: sum of 2 quarters · filed 2024-03-28 | -$10.30M derived: sum of 3 quarters · filed 2024-03-28 | -$13.16M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$3.42M 10-Q · filed 2023-11-14 | -$6.99M derived: sum of 2 quarters · filed 2023-11-14 | -$9.84M 10-Q · filed 2023-11-14 | -$12.92M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$3.57M 10-Q · filed 2023-08-14 | -$6.43M 10-Q · filed 2023-08-14 | -$9.50M derived: sum of 3 quarters · filed 2023-08-14 | -$12.15M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$2.86M 10-Q · filed 2023-05-15 | -$5.93M derived: sum of 2 quarters · filed 2023-05-15 | -$8.58M derived: sum of 3 quarters · filed 2023-05-15 | -$11.78M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$5.72M derived: sum of 2 quarters · filed 2023-03-16 | -$8.92M derived: sum of 3 quarters · filed 2023-03-16 | -$11.50M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$2.65M 10-Q · filed 2022-11-14 | -$5.85M derived: sum of 2 quarters · filed 2022-11-14 | -$8.43M 10-Q · filed 2022-11-14 | -$10.68M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$3.20M 10-Q · filed 2022-08-15 | -$5.78M 10-Q · filed 2022-08-15 | -$8.03M derived: sum of 3 quarters · filed 2022-08-15 | -$11.29M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$2.58M 10-Q · filed 2022-05-12 | -$4.83M derived: sum of 2 quarters · filed 2022-05-12 | -$8.09M derived: sum of 3 quarters · filed 2022-05-12 | -$10.98M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$5.51M derived: sum of 2 quarters · filed 2022-03-30 | -$8.40M derived: sum of 3 quarters · filed 2022-03-30 | -$11.50M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | -$3.26M 10-Q · filed 2021-11-15 | -$6.15M derived: sum of 2 quarters · filed 2021-11-15 | -$9.25M 10-Q · filed 2021-11-15 | -$12.38M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$2.89M 10-Q · filed 2021-08-12 | -$5.99M 10-Q · filed 2021-08-12 | -$9.12M derived: sum of 3 quarters · filed 2021-08-12 | -$11.76M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$3.10M 10-Q · filed 2021-05-17 | -$6.23M derived: sum of 2 quarters · filed 2021-05-17 | -$8.87M derived: sum of 3 quarters · filed 2021-05-17 | -$11.20M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$5.77M derived: sum of 2 quarters · filed 2021-03-25 | -$8.10M derived: sum of 3 quarters · filed 2021-03-25 | -$10.84M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | -$2.64M 10-Q · filed 2020-11-16 | -$4.97M derived: sum of 2 quarters · filed 2020-11-16 | -$7.71M 10-Q · filed 2020-11-16 | -$9.72M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | -$2.33M 10-Q · filed 2020-08-14 | -$2.33M 10-Q · filed 2019-08-08 | -$5.07M 10-Q · filed 2020-08-14 | -$7.08M derived: sum of 3 quarters · filed 2020-08-14 | -$9.43M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$2.75M 10-Q · filed 2020-05-14 | -$4.75M derived: sum of 2 quarters · filed 2020-05-14 | -$7.11M derived: sum of 3 quarters · filed 2020-05-14 | -$8.93M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$4.36M derived: sum of 2 quarters · filed 2020-03-26 | -$6.18M derived: sum of 3 quarters · filed 2020-03-26 | -$9.02M 10-K · filed 2020-03-26 | ||
| 2018-09-30 | -$2.36M 10-Q · filed 2019-11-13 | -$2.36M 10-Q · filed 2018-11-05 | -$4.18M derived: sum of 2 quarters · filed 2019-11-13 | -$7.02M 10-Q · filed 2019-11-13 | -$9.31M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | -$1.82M 10-Q · filed 2019-08-08 | -$4.66M 10-Q · filed 2019-08-08 | -$6.96M derived: sum of 3 quarters · filed 2019-08-08 | -$7.87M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | -$2.84M 10-Q · filed 2019-05-14 | -$5.13M derived: sum of 2 quarters · filed 2019-05-14 | -$6.05M derived: sum of 3 quarters · filed 2019-05-14 | -$7.10M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$3.21M derived: sum of 2 quarters · filed 2019-03-11 | -$4.26M derived: sum of 3 quarters · filed 2019-03-11 | -$4.63M 10-K · filed 2019-03-11 | ||
| 2017-09-30 | -$910.93K 10-Q · filed 2018-11-05 | -$1.97M derived: sum of 2 quarters · filed 2018-11-05 | -$2.33M 10-Q · filed 2018-11-05 | -$2.65M derived: sum of 4 quarters · filed 2018-11-05 | ||
| 2017-06-30 | -$1.06M 10-Q · filed 2018-08-13 | -$1.06M 10-Q · filed 2017-08-07 | -$1.42M 10-Q · filed 2018-08-13 | -$1.42M 10-Q · filed 2017-08-07 | -$1.74M derived: sum of 3 quarters · filed 2018-08-13 | -$2.34M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | -$360.70K 10-Q · filed 2018-05-15 | -$360.70K 10-Q · filed 2017-06-21 | -$679.58K derived: sum of 2 quarters · filed 2018-05-15 | -$1.28M derived: sum of 3 quarters · filed 2018-05-15 | -$1.78M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$318.88K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$923.99K derived: sum of 2 quarters · filed 2018-03-20 | -$1.42M derived: sum of 3 quarters · filed 2018-03-20 | -$1.79M 10-K · filed 2018-03-20 | ||
| 2016-09-30 | -$605.11K 10-Q · filed 2017-11-14 | -$1.10M derived: sum of 2 quarters · filed 2017-11-14 | -$1.47M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | -$494.31K 10-Q · filed 2017-08-07 | -$867.77K 10-Q · filed 2017-08-07 | ||||
| 2016-03-31 | -$373.46K 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |